Get the Stockscreener App
0.95
7.82%
0.0689
After Hours:
.93
-0.02
-2.11%
Aptorum Group Ltd stock is traded at $0.95, with a volume of 34,479.
It is up +7.82% in the last 24 hours and up +19.96% over the past month.
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Aptorum's project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA). Substantially all of the company's revenues are derived from within Hong Kong.
See More
Previous Close:
$0.8811
Open:
$0.921
24h Volume:
34,479
Relative Volume:
0.56
Market Cap:
$7.74M
Revenue:
$431.40K
Net Income/Loss:
$-1.95M
P/E Ratio:
-7.6737
EPS:
-0.1238
Net Cash Flow:
$-726.80K
1W Performance:
+10.99%
1M Performance:
+19.96%
6M Performance:
-39.49%
1Y Performance:
-12.04%
1-Day Range:
$0.89
$0.95
1-Week Range:
$0.82
$0.95
52-Week Range:
$0.65
$4.47
Aptorum Group Ltd Stock (APM) Company Profile
Compare APM vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APM
Aptorum Group Ltd
|
0.95 | 7.18M | 431.40K | -1.95M | -726.80K | -0.1238 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aptorum Group Ltd Stock (APM) Latest News
XBIO PE Ratio & Valuation, Is XBIO Overvalued - Intellectia AI
APRE PE Ratio & Valuation, Is APRE Overvalued - Intellectia AI
APM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aptorum Group Soars Over 20% as Market Deciphers Regulatory Chaos and Sector Growth Signals - Bitget
DiamiR merger gives Aptorum (NASDAQ: APM) holders 30% of new Niki BioSolutions - stocktitan.net
Aptorum (NASDAQ: APM) to merge with DiamiR; domestication and share issuance - Stock Titan
Direxion Daily AMZN Bull 2X Shares (NASDAQ:AMZU) Short Interest Up 22.7% in March - Defense World
APTORUM GROUP PB Ratio: 0.29 | Possible Value Trap - GuruFocus
Going concern warning and high risk profile at Aptorum Group (NASDAQ: APM) - Stock Titan
Aptorum (NASDAQ: APM) delays DiamiR merger cutoff to June 30, 2026 - Stock Titan
If You Invested $1,000 in Aptorum Group Ltd (APM) - Stock Titan
Aptorum Group (APM) Stock Analysis Report | Financials & Insights - Benzinga Japan
[6-K] Aptorum Group Ltd Current Report (Foreign Issuer) | APM SEC FilingForm 6-K - Stock Titan
Aptorum, DiamiR publish glioblastoma blood test study By Investing.com - Investing.com South Africa
Aptorum, DiamiR publish glioblastoma blood test study - Investing.com Nigeria
Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania - Bitget
Blood test study takes aim at glioblastoma, deadliest brain cancer - Stock Titan
Aptorum Group Receives Nasdaq Compliance Notification - Intellectia AI
APM | Aptorum Group Limited Class FinancialsIncome Statement - Quiver Quantitative
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - The Chronicle-Journal
Biotech Aptorum faces Nasdaq $1 warning but keeps listing for now - Stock Titan
APM Should I Buy - Intellectia AI
Aptorum Group Limited (NASDAQ:APM) Short Interest Up 232.3% in February - Defense World
Aptorum Group Ltd (APM) Income Statement - TradingKey
APMAptorum Group Ltd Latest Stock News & Market Updates - Stock Titan
Can Aptorum Group Limited stock outperform in a bear marketTrade Risk Summary & Target Return Focused Stock Picks - mfd.ru
APM PE Ratio & Valuation, Is APM Overvalued - Intellectia AI
Exit Recap: Is Aptorum Group Limited forming a double bottom2025 Support & Resistance & Weekly Top Stock Performers List - baoquankhu1.vn
CEO Change: Will Aptorum Group Limited stock hit new highs in YEARTrade Performance Summary & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Aptorum Group schedules 2025 annual general meeting for March in Hong Kong By Investing.com - Investing.com South Africa
Aptorum Group schedules 2025 annual general meeting for March in Hong Kong - Investing.com
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease - The Manila Times
Automated Alzheimer’s risk gene test to be vetted in DiamiR lab - Stock Titan
Will Aptorum Group Limited outperform small cap indexes2025 Risk Factors & Precise Buy Zone Identification - mfd.ru
Andean Precious Metals Announces C$83.1 Million Bought Public Secondary Offering of Common Shares - markets.businessinsider.com
Trend Recap: Can Aptorum Group Limited continue delivering strong returnsJuly 2025 Intraday Action & Expert Approved Momentum Ideas - baoquankhu1.vn
Aptorum Group (NASDAQ:APM) vs. BioNxt Solutions (OTCMKTS:BNXTF) Head-To-Head Review - Defense World
Can Aptorum Group Limited stock hit analyst price targetsJuly 2025 Update & Daily Chart Pattern Signal Reports - Улправда
Sentiment Review: Will Aptorum Group Limited stock benefit from upcoming earnings reportsJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - Улправда
Aptorum Group Limited (NASDAQ:APM) Sees Significant Decline in Short Interest - Defense World
Aptorum Group (NASDAQ:APM) Stock Price Up 3.5% – Should You Buy? - Defense World
How interest rate cuts could boost Aptorum Group Limited stockQuarterly Trade Report & Community Verified Watchlist Alerts - Улправда
Can Aptorum Group Limited stock beat market expectations this quarter2025 Support & Resistance & Fast Entry High Yield Stock Tips - Улправда
Aptorum Group Limited (APM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Aptorum Group Limited stock a buy before product launches - newser.com
The time has not yet come to remove your chips from the table: Aptorum Group Ltd (APM) - Setenews
DiamiR and Aptorum Group (NASDAQ: APM) to Present Alzheimer’s microRNA Data at CTAD 2025 - Stock Titan
Applying Wyckoff theory to Aptorum Group Limited stock2025 Trade Ideas & Fast Gain Swing Alerts - newser.com
DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 Conference - Yahoo Finance
Aptorum Group LimitedClass A Ordinary Shares (Nasdaq:APM) Stock Quote - FinancialContent
[F-1] Aptorum Group Ltd Foreign Issuer IPO Registration | APM SEC FilingForm F-1 - Stock Titan
Aptorum Group Ltd Stock (APM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):